Stoke Therapeutics is a biotechnology company focused on restoring protein expression through RNA medicine. By leveraging its proprietary TANGO approach, Stoke is developing antisense oligonucleotides (ASOs) to selectively target and restore protein levels, initially addressing diseases related to the central nervous system and the eye caused by haploinsufficiency.
No jobs found. Subscribe below to get notified when we find something for you.
Searching